About ShakSaeed

This author has not yet filled in any details.
So far ShakSaeed has created 6 blog entries.

Audion Therapeutics and REGAIN Consortium announce positive Phase I Results in patients with sensorineural hearing loss

By |2019-09-08T20:45:34+01:00February 5th, 2019|

The REGAIN consortium, led by Audion Therapeutics BV, a company dedicated to the development of therapeutics for hearing loss, today reports positive results from its Phase I multiple ascending dose, open-label safety study of the Notch Inhibitor LY3056480 in 15 patients with mild to moderate sensorineural hearing loss

Go to Top